Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology

Acta Haematologica
Nili Ronit Schamroth Pravda, Ran Kornowski

Abstract

With the increasing survival of cancer patients and therapeutic advancements, the cardiovascular complications of therapy have become a significant issue. A dedicated, integrated team is important in providing the balance between acquiring a hematological/oncological response and cardiovascular morbidity and mortality. This article aims to shed light on this field - providing some examples of therapies with cardiotoxic potential as well as the cardiologist's approach to patient assessment before, during, and after therapy.

References

Dec 21, 2007·Leukemia·A PalumboUNKNOWN International Myeloma Working Group
Sep 16, 2010·Nature Reviews. Cardiology·Michael S Ewer, Steven M Ewer
Mar 5, 2011·The American Journal of Cardiology·Heloisa SawayaMarielle Scherrer-Crosbie
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Elvira C van DalenLeontien Cm Kremer
Nov 5, 2013·The New England Journal of Medicine·J E CortesUNKNOWN PACE Investigators
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PalumboRobert Z Orlowski
Mar 26, 2016·Journal of the American College of Cardiology·Dorothy M GujralSanjeev Bhattacharyya
Nov 3, 2016·The New England Journal of Medicine·Douglas B JohnsonJavid J Moslehi

❮ Previous
Next ❯

Citations

Feb 23, 2021·Disease Markers·Anca BojanAndrada Parvu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Related Papers

Schizophrenia Bulletin
William Carpenter
Hospital Progress
R D Wheelock
Journal of the American College of Cardiology
Biniyam G DemisseiBonnie Ky
Nursing Times
M George
© 2022 Meta ULC. All rights reserved